mefloquine has been researched along with Alveolar Echinococcosis, Hepatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boubaker, G; Gorgas, D; Gottstein, B; Hemphill, A; Müller, J; Müller, N; Rufener, R; Spiliotis, M; Stadelmann, B | 1 |
| Hemphill, A; Hermann, C; Keiser, J; Küster, T; Scholl, S; Stadelmann, B | 1 |
1 review(s) available for mefloquine and Alveolar Echinococcosis, Hepatic
| Article | Year |
|---|---|
Treatment of echinococcosis: albendazole and mebendazole--what else?
Topics: Albendazole; Animals; Anthelmintics; Cell Division; Clarithromycin; Cytostatic Agents; Drug Design; Drug Evaluation, Preclinical; Echinococcosis; Echinococcosis, Hepatic; Echinococcus multilocularis; Forecasting; Guanidines; Helminth Proteins; Host-Parasite Interactions; Humans; Imidazoles; Larva; Mebendazole; Mefloquine; Mice; Molecular Targeted Therapy; Nitro Compounds; Thiazoles; Thiophenes | 2014 |
1 other study(ies) available for mefloquine and Alveolar Echinococcosis, Hepatic
| Article | Year |
|---|---|
In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Topics: Albendazole; Animals; Antiparasitic Agents; Disease Models, Animal; Echinococcosis; Echinococcosis, Hepatic; Echinococcus multilocularis; Female; Humans; Mefloquine; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Parasitic Sensitivity Tests; Treatment Outcome | 2011 |